AppPage.net

Screenshots

  • J3M-MC-JZQB screenshot 1
  • J3M-MC-JZQB screenshot 2
  • J3M-MC-JZQB screenshot 3
  • J3M-MC-JZQB screenshot 4

About J3M-MC-JZQB

A Multicenter, Randomized, Phase 3 Study Comparing LY3537982 and Pembrolizumab to Placebo and Pembrolizumab as First-Line Treatment in Patients with KRAS G12C-Mutant, Locally Advanced or Metastatic Non-Small Cell Lung Cancer with High PD-L1 Expression (TPS ≥ 50%). This app is specifically intended for participants in the J3M-MC-JZQB study only.

What’s new

Version 5.4.1101 · Updated November 21, 2025

This update includes improvements and bug fixes to enhance your experience.

App privacy

The developer, Medable, Inc., reported these privacy practices to Apple.

Data Linked to You

The following data, which may be collected and linked to your identity, may be used for the following purposes:

  • Health & Fitness: Health
  • Identifiers: User ID, Device ID
  • Diagnostics: Crash Data

Used for: App Functionality

Alternatives to J3M-MC-JZQB

Looking for apps like J3M-MC-JZQB? Here are 6 similar apps on the App Store.

J3M-MC-JZQB vs. alternatives
App Rating Price Last updated Compare
J3M-MC-JZQB – Free November 21, 2025
ACHIEVE-PEDS – Free Oct 22, 2026 Compare
ATTAIN-NOW – Free Oct 22, 2026 Compare
Daiichi DS8201-793 – Free Oct 30, 2025 Compare
Janssen 61186372NSC2007 COCOON – Free Nov 16, 2025 Compare
5th Element Wellness – Free Sep 20, 2025 Compare
Fifth Element Wellness – Free Oct 23, 2026 Compare

Compare J3M-MC-JZQB with the top alternatives: ratings, updates, ASO score and keyword gaps →